Using advanced MRI techniques to improve radiation therapy for prostate cancer
Quantitative MRI to automatically delineate intraprostatic tumor for radiation therapy
This study is working on a new MRI tool to help doctors better see and target prostate cancer tumors during radiation therapy, which could lead to more effective treatments for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Beckman Research Institute/city of Hope NIH-funded |
| Lab location | 1 site (Duarte, United States) |
| Project ID | NIH-10982242 on NIH RePORTER |
What this research studies
This research focuses on enhancing radiation therapy for prostate cancer by developing a new quantitative MRI tool that can automatically identify and delineate significant tumor areas within the prostate. By utilizing advanced imaging techniques such as magnetic resonance fingerprinting and diffusion-weighted MRI, the project aims to create detailed 3D maps that reflect the tumor's physiological and pathological characteristics. This approach seeks to improve the accuracy of tumor targeting during radiation therapy, potentially leading to better treatment outcomes for patients. The research will also address current limitations in MRI interpretation that can affect treatment decisions.
Who could benefit from this research
Good fit: Ideal candidates for this research are men diagnosed with intermediate- to high-risk prostate cancer who are undergoing radiation therapy.
Not a fit: Patients with low-risk prostate cancer or those not receiving radiation therapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective radiation therapy for prostate cancer, improving survival rates and reducing the risk of local recurrences.
How similar studies have performed: Previous research has shown promise in using advanced imaging techniques for cancer treatment, indicating that this approach could lead to significant advancements in prostate cancer therapy.
Where this research is happening
Duarte, United States
- Beckman Research Institute/city of Hope — Duarte, United States (Active)
Researchers
- Principal investigator: Qing, Kun — Beckman Research Institute/city of Hope
- Study coordinator: Qing, Kun
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.